# IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial

> **NCT05971394** · NA · RECRUITING · sponsor: **Biotyx Medical (Shenzhen) Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- Infrapopliteal Lesions
- Critical Limb Ischemia

## Interventions

- **DEVICE:** Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System (IBS Titan™)

## Key facts

- **NCT ID:** NCT05971394
- **Lead sponsor:** Biotyx Medical (Shenzhen) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-07-17
- **Primary completion:** 2026-01
- **Final completion:** 2026-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-08-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05971394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05971394, "IBS Titan™ Sirolimus-eluting Iron Bioresorbable Peripheral Scaffold System Clinical Trial". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05971394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*